CervoMed Inc.CRVONASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 7.90% |
| Q3 2025 | -28.76% |
| Q2 2025 | 37.05% |
| Q1 2025 | 2.86% |
| Q4 2024 | 4.76% |
| Q3 2024 | -11.97% |
| Q2 2024 | 18.03% |
| Q1 2024 | 0.58% |
| Q4 2023 | -12.22% |
| Q3 2023 | 142.82% |
| Q2 2023 | -0.84% |
| Q1 2023 | -57.31% |
| Q4 2022 | 308.77% |
| Q3 2022 | -73.17% |
| Q2 2022 | 0.41% |
| Q1 2022 | 10.01% |
| Q4 2021 | 0.25% |
| Q3 2021 | 5.08% |
| Q2 2021 | 5.35% |
| Q1 2021 | 17.83% |
| Q4 2020 | -29.95% |
| Q3 2020 | 44.86% |
| Q2 2020 | 4.62% |
| Q1 2020 | 9.34% |
| Q4 2019 | -1.21% |
| Q3 2019 | 20.82% |
| Q2 2019 | -11.05% |
| Q1 2019 | -15.38% |
| Q4 2018 | -10.73% |
| Q3 2018 | -4.28% |
| Q2 2018 | 10.86% |
| Q1 2018 | 16.76% |
| Q4 2017 | -17.70% |
| Q3 2017 | -13.20% |
| Q2 2017 | 15.65% |
| Q1 2017 | 51.81% |
| Q4 2016 | -73.45% |
| Q3 2016 | 63.99% |
| Q2 2016 | -39.18% |
| Q1 2016 | 47.82% |